RecruitingNot ApplicableNCT07615686

tSCS in Children With Spina Bifida

Transcutaneous Spinal Cord Stimulation to Improve Strength and Gait in Children With Spina Bifida

Sponsor

Bailey Petersen

Enrollment

20 participants

Start Date

Jun 10, 2026

Study Type

INTERVENTIONAL

Conditions

Myelomeningocele Spina Bifida

Summary

A single-center, open-label, investigational pilot trial to explore potential effects of transcutaneous spinal cord stimulation on leg muscle strength and walking in children with myelomeningocele.

Eligibility

Min Age: 4 YearsMax Age: 17 Years

Inclusion Criteria5

Diagnosed myelomeningocele confirmed by a neurosurgeon or neurologist
Some difficulty ambulating, but able to ambulate at least a short distance (10 meters) with devices and/or assistance.
Between the ages of 4 and 17 years of age.
Documented neurogenic bladder dysfunction
On a stable bladder management regimen at least 4-6 weeks prior to the enrollment in the trial

Exclusion Criteria6

Severe behavioral or cognitive impairments that preclude participation in the study, in the opinion of the investigator.
Has an active surgery planned for impairments from spina bifida (e.g. tethered cord syndrome surgery or orthopedic surgery) or has had surgery in the last 6 months.
Is pregnant. Pregnancy will be assessed via verbal report.
Open wounds at the thoracic or lumbar spine that precludes transcutaneous stimulation.
Implanted or attached electronic device in any location of the body (e.g. pacemakers, baclofen pumps, or implanted insulin pumps)
Symptomatic urinary tract infection, urinary tract infection for which they are currently receiving treatment, scheduled urological surgery, or inability to perform or receive catheterization.